/Investor DB

LeVert Ventures — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Upstreambiotechupstreambiotech.comSep 2025

Upstream Biotechnology develops seed-based crop technologies that enhance plant immunity and resilience using RNA-based SwitchBlade platform.

AgTechBiotechClimate TechDurham, US

George H. Greene(CEO & Co-Founder)Xiao-fang Wang(Director)Xinnian Dong(Co-Founder)

Board seatKaren LeVert· per SEC Form D

Co-investorsAg Ventures AllianceAgLaunch AcceleratorMiddleland CapitalRedstick Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.